Scientists hoping to discover better ways to boost immune function — which could lengthen our healthspan and protect immunocompromised patients — may have a new target, according to findings published ...
Researchers from Apogee Therapeutics Inc. and Paragon Therapeutics Inc. have reported the preclinical characterization of APG-333, a half-life extended monoclonal antibody targeting thymic stromal ...
French researchers have used a protein called receptor activator of NF-κB ligand (RANKL) to revive the structure and function of the thymus in old mice. The thymus sits in front of the heart and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results